SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy

1. Bamias, A.
2. Merseburger, A.S.
3. Loriot, Y.
4. James, N.
5. Choy, E.
6. Castellano, D.
7. Lopez-Rios, F.
8. Calabrò, F.
9. Kramer, M.
10. de Velasco, G.
11. Zakopoulou, R.
12. Tzannis, K.
13. Sternberg, C.N.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.ESMOOP.2021.100152 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus